• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Interpreta, higi, Partners to Integrate Biometric Data for Patient Engagement

by Jasmine Pennic 08/22/2017 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Interpreta, higi, Partners to Integrate Biometric Data for Patient Engagement

Interpreta and higi are announcing a partnership to integrate biometric data from higi with clinical, claims and genomic data from Interpreta. The integration will enable patients and their physicians to increase engagement and share healthcare data (on blood pressure, pulse, BMI, weight, body composition, and self-screening questions) gained at higi retail stations and prioritized within Interpreta in real time.

This will enable physicians and insurers to leverage a patient’s biometrics data, alongside clinical, claims and additional genomic information a person may obtain from genetic testing services. For the first time, healthcare payers and providers will be able to jointly create a robust personalized care roadmap, inform care decisions, and more effectively close gaps in care with the help of engaged consumers at a retail setting.

With the growth in wearable devices and health apps, consumers are increasingly looking for greater options to take charge of their health. higi has the largest self-screening health station network with 43 million consumers having used its nearly 11,000 stations at leading food, chain drug, mass merchant and club locations (78 percent of the U.S. population is within five miles of a higi station) to capture biometrics during routine shopping activity. Consumers can access the information gained at higi stations (currently at select Ahold Delhaize, Albertsons, Fred’s, H-E-B Grocery Stores, Kroger, Meijer, Publix, Rite Aid, Sam’s Club, Shopko, ShopRite, SuperValu, and Wegmans) from its mobile and web app, helping them to measure what matters, giving them the option to share their data with their providers, and incentivizing them to transform their health.

“With higi capturing important consumer health data and Interpreta’s ability to interpret and integrate it with clinical and genomic data in real time, this alliance will be the first of its kind to bring such power to the retail setting,” said Interpreta CEO and Co-founder Ahmed Ghouri, M.D. in a statement. “The integration will bring consumers and providers together like never before, giving them access to the same continuously updated healthcare information and non-latent interpretations to make the best choices for care.”

 

To date, more than 41 million people have used a higi health station to conduct over 228 million biometric screenings (blood pressure, pulse, weight, body mass index). Over 5.5 million people have signed up for a higi account, which offers an all-in-one biometric and activity data feed for personal health management and information sharing with friends, family, and trusted healthcare providers.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: genomic data, Genomic Data Interpretation, higi, Interpreta

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |